Vericel Operating Income from 2010 to 2026

VCEL Stock

USD 38.04 0.63 1.68%

Vericel Corp Operating Income yearly trend continues to be quite stable with very little volatility. Operating Income may rise above about 5.5 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Vericel Corp Ord generates from its operations. View All Fundamentals

Operating Income

First Reported

1996-09-30

Previous Quarter

-2 M

Current Value

3.5 M

Quarterly Volatility

4.6 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Vericel Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vericel Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.6 M, Interest Expense of 741.4 K or Total Revenue of 286.4 M, as well as many indicators such as Price To Sales Ratio of 9.67, Dividend Yield of 0.0 or PTB Ratio of 4.46. Vericel financial statements analysis is a perfect complement when working with Vericel Corp Valuation or Volatility modules.

Build AI portfolio with Vericel Stock

Check out the analysis of Vericel Corp Correlation against competitors.

Historical Operating Income data for Vericel Corp serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Vericel Corp Ord represents a compelling investment opportunity.

Latest Vericel Corp's Operating Income Growth Pattern

Below is the plot of the Operating Income of Vericel Corp Ord over the last few years. Operating Income is the amount of profit realized from Vericel Corp Ord operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Vericel Corp Ord is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Vericel Corp's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vericel Corp's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Vericel Operating Income Regression Statistics

	Arithmetic Mean	(11,628,792)
	Coefficient Of Variation	(102.65)
	Mean Deviation	9,673,608
	Median	(11,251,000)
	Standard Deviation	11,936,578
	Sample Variance	142.5T
	Range	39.2M
	R-Value	0.80
	Mean Square Error	55.4T
	R-Squared	0.64
	Significance	0.0001
	Slope	1,884,332
	Total Sum of Squares	2279.7T

Vericel Operating Income History

	2026	5.5 M
	2025	5.2 M
	2024	4.5 M
	2023	-6.5 M
	2022	-17.1 M
	2021	-7.9 M
	2020	2.4 M

Other Fundumenentals of Vericel Corp Ord

Non Operating Income Net Other

Vericel Corp Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Intangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		1.0	0.81	-0.5	0.96	0.98	0.99	0.98	0.95	0.72	0.95	0.92	0.2	0.79	0.93	-0.17	0.76	0.39	0.93	0.92	0.92	0.9
Total Stockholder Equity	1.0		0.79	-0.5	0.95	0.98	0.97	0.98	0.96	0.75	0.96	0.92	0.22	0.8	0.94	-0.2	0.79	0.39	0.93	0.93	0.91	0.89
Net Debt	0.81	0.79		-0.22	0.77	0.79	0.85	0.73	0.81	0.51	0.71	0.75	-0.04	0.6	0.71	-0.12	0.48	0.27	0.75	0.69	0.77	0.77
Retained Earnings	-0.5	-0.5	-0.22		-0.48	-0.59	-0.48	-0.59	-0.47	-0.44	-0.71	-0.55	-0.55	-0.63	-0.58	-0.1	-0.63	-0.51	-0.5	-0.56	-0.38	-0.4
Accounts Payable	0.96	0.95	0.77	-0.48		0.95	0.96	0.93	0.9	0.62	0.91	0.82	0.02	0.67	0.83	-0.14	0.65	0.37	0.88	0.86	0.92	0.85
Net Receivables	0.98	0.98	0.79	-0.59	0.95		0.97	0.99	0.94	0.75	0.97	0.93	0.27	0.84	0.92	-0.1	0.8	0.49	0.91	0.93	0.88	0.86
Total Liab	0.99	0.97	0.85	-0.48	0.96	0.97		0.95	0.91	0.63	0.93	0.91	0.15	0.75	0.89	-0.11	0.68	0.39	0.91	0.89	0.92	0.91
Total Current Assets	0.98	0.98	0.73	-0.59	0.93	0.99	0.95		0.94	0.81	0.97	0.94	0.31	0.86	0.96	-0.15	0.85	0.45	0.92	0.95	0.87	0.85
Short Term Debt	0.95	0.96	0.81	-0.47	0.9	0.94	0.91	0.94		0.79	0.92	0.83	0.21	0.8	0.89	-0.21	0.79	0.41	0.88	0.88	0.84	0.82
Short Term Investments	0.72	0.75	0.51	-0.44	0.62	0.75	0.63	0.81	0.79		0.74	0.75	0.36	0.83	0.84	-0.27	0.89	0.35	0.72	0.83	0.58	0.56
Common Stock	0.95	0.96	0.71	-0.71	0.91	0.97	0.93	0.97	0.92	0.74		0.9	0.37	0.86	0.93	-0.07	0.83	0.48	0.87	0.9	0.83	0.82
Property Plant Equipment	0.92	0.92	0.75	-0.55	0.82	0.93	0.91	0.94	0.83	0.75	0.9		0.39	0.81	0.94	-0.21	0.83	0.38	0.88	0.92	0.82	0.86
Current Deferred Revenue	0.2	0.22	-0.04	-0.55	0.02	0.27	0.15	0.31	0.21	0.36	0.37	0.39		0.53	0.34	0.08	0.58	0.37	0.16	0.27	-0.01	0.16
Long Term Debt	0.79	0.8	0.6	-0.63	0.67	0.84	0.75	0.86	0.8	0.83	0.86	0.81	0.53		0.87	0.2	0.83	0.45	0.75	0.82	0.63	0.65
Net Tangible Assets	0.93	0.94	0.71	-0.58	0.83	0.92	0.89	0.96	0.89	0.84	0.93	0.94	0.34	0.87		-0.19	0.85	0.36	0.89	0.95	0.82	0.82
Long Term Debt Total	-0.17	-0.2	-0.12	-0.1	-0.14	-0.1	-0.11	-0.15	-0.21	-0.27	-0.07	-0.21	0.08	0.2	-0.19		-0.3	0.09	-0.21	-0.23	-0.17	-0.18
Intangible Assets	0.76	0.79	0.48	-0.63	0.65	0.8	0.68	0.85	0.79	0.89	0.83	0.83	0.58	0.83	0.85	-0.3		0.31	0.75	0.85	0.59	0.62
Short Long Term Debt	0.39	0.39	0.27	-0.51	0.37	0.49	0.39	0.45	0.41	0.35	0.48	0.38	0.37	0.45	0.36	0.09	0.31		0.36	0.38	0.31	0.31
Net Invested Capital	0.93	0.93	0.75	-0.5	0.88	0.91	0.91	0.92	0.88	0.72	0.87	0.88	0.16	0.75	0.89	-0.21	0.75	0.36		0.97	0.96	0.95
Net Working Capital	0.92	0.93	0.69	-0.56	0.86	0.93	0.89	0.95	0.88	0.83	0.9	0.92	0.27	0.82	0.95	-0.23	0.85	0.38	0.97		0.9	0.88
Capital Stock	0.92	0.91	0.77	-0.38	0.92	0.88	0.92	0.87	0.84	0.58	0.83	0.82	-0.01	0.63	0.82	-0.17	0.59	0.31	0.96	0.9		0.96
Long Term Investments	0.9	0.89	0.77	-0.4	0.85	0.86	0.91	0.85	0.82	0.56	0.82	0.86	0.16	0.65	0.82	-0.18	0.62	0.31	0.95	0.88	0.96

Click cells to compare fundamentals

About Vericel Corp Financial Statements

Vericel Corp investors utilize fundamental indicators, such as Operating Income, to predict how Vericel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	5.2 M	5.5 M
Non Operating Income Net Other	1.3 M	1.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Vericel Corp Correlation against competitors.

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Quarterly Earnings Growth

0.476

Earnings Share

0.26

Revenue Per Share

5.168

Quarterly Revenue Growth

0.166

Return On Assets

0.0105

Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Vericel Operating Income from 2010 to 2026

Latest Vericel Corp's Operating Income Growth Pattern

Vericel Operating Income Regression Statistics

Vericel Operating Income History

Other Fundumenentals of Vericel Corp Ord

Vericel Corp Operating Income component correlations

About Vericel Corp Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY